Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC August Update

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Rotigotine (Neupro®) has been accepted for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults. Treatment should only be used in patients who score 15 points or more on the International Restless Legs Scale (IRLS).

Calcipotriol and betamethasone gel (Xamiol®) has been accepted for the topical treatment of scalp psoriasis. The combination product has been shown to be more effective than monotherapy in short-term studies.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC August Update' on Email Share 'SMC August Update' on Delicious Share 'SMC August Update' on Digg Share 'SMC August Update' on Facebook Share 'SMC August Update' on Google+ Share 'SMC August Update' on reddit Share 'SMC August Update' on StumbleUpon Share 'SMC August Update' on Twitter

atomic-wealth

No Comments to “SMC August Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,321 spam comments.

atomic-wealth
fond-illness
summer